Table 1.
Baseline Demographic and Clinical Characteristics
| Characteristic | Cases With NVHAP (n = 174) | Control Subjects Without NVHAP (n = 696) | P Value |
|---|---|---|---|
| Age, y | 57.5 ± 15.0 | 57.5 ± 14.9 | 1.0 |
| Male sex, No. (%) | 95 (54.6) | 380 (54.6) | 1.0 |
| White, No. (%) | 124 (71.3) | 523 (75.4) | .27 |
| African American, No. (%) | 37 (21.3) | 167 (24.1) | .44 |
| Charlson comorbidity score | 5.5 ± 3.2 | 4.8 ± 3.4 | .02 |
| Coronary artery disease, No. (%) | 28 (16.1) | 106 (15.2) | .78 |
| Congestive heart failure, No. (%) | 46 (26.4) | 151 (21.7) | .18 |
| Cerebrovascular disease, No. (%) | 19 (10.9) | 89 (12.8) | .50 |
| COPD, No. (%) | 89 (51.1) | 225 (32.3) | < .01 |
| Cirrhosis, No. (%) | 36 (20.7) | 114 (16.4) | .18 |
| Diabetes, No. (%) | 57 (32.8) | 255 (36.6) | .34 |
| Active malignancy, No. (%) | 21 (12.1) | 80 (11.5) | .83 |
| Chronic kidney disease, No. (%) | 38 (21.8) | 162 (23.3) | .69 |
| Surgical patient, No. (%) | 75 (43.1) | 291 (41.8) | .76 |
| Medical patient, No. (%) | 99 (56.9) | 405 (58.2) | .75 |
Values expressed as mean ± SD or No. (percent). NVHAP = nonventilated hospital-acquired pneumonia.